Laura Mannarino

860 total citations
24 papers, 498 citations indexed

About

Laura Mannarino is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Laura Mannarino has authored 24 papers receiving a total of 498 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 11 papers in Pulmonary and Respiratory Medicine and 9 papers in Cancer Research. Recurrent topics in Laura Mannarino's work include Occupational and environmental lung diseases (6 papers), Cancer Research and Treatments (4 papers) and Cancer-related molecular mechanisms research (4 papers). Laura Mannarino is often cited by papers focused on Occupational and environmental lung diseases (6 papers), Cancer Research and Treatments (4 papers) and Cancer-related molecular mechanisms research (4 papers). Laura Mannarino collaborates with scholars based in Italy, United Kingdom and Japan. Laura Mannarino's co-authors include Maurizio D’Incalci, Sergio Marchini, Claudia Nastasi, Ilaria Craparotta, Luca Beltrame, Lara Paracchini, Paola Allavena, Roberta Frapolli, Cristina Belgiovine and Manuela Liguori and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Cancer Research and International Journal of Molecular Sciences.

In The Last Decade

Laura Mannarino

21 papers receiving 496 citations

Peers

Countries citing papers authored by Laura Mannarino

Since Specialization

Citations

This map shows the geographic impact of Laura Mannarino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Mannarino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Mannarino more than expected).

Fields of papers citing papers by Laura Mannarino

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Mannarino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Mannarino. The network helps show where Laura Mannarino may publish in the future.

Co-authorship network of co-authors of Laura Mannarino

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Mannarino. A scholar is included among the top collaborators of Laura Mannarino based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Mannarino. Laura Mannarino is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Immune evasion mechanisms in early-stage I high-grade serous ovarian carcinoma: insights into regulatory T cell dynamics 2025 ·Cell Death and Disease ·Joanna Mikulak, (unknown), (unknown), (unknown), (unknown), Rocco Piazza, (unknown), Domenico Vitobello, (unknown), Fabio Grizzi, (unknown), Barbara Fiamengo, Gianluca Basso, (unknown), Laura Mannarino, Maurizio D’Incalci, Sergio Marchini, Domenico Mavilio	2
2	Malignant mesothelioma-associated inflammatory microenvironment promotes tumor progression via GPNMB 2025 ·Journal of Translational Medicine ·Cristina Belgiovine, Elisabeth Digifico, Marco Erreni, (unknown), Laura Mannarino, Sonia Valentino, Fabio Grizzi, Fabio Pasqualini, Camilla Recordati, (unknown), Paolo Andrea Zucali, Daniela Pistillo, (unknown), (unknown), Maurizio D’Incalci, Federica Marchesi, Paola Allavena	1
3	Pleural mesothelioma: Long-term progression-free survival with Tumor Treating Fields (TTFields) therapy case reports 2024 ·SHILAP Revista de lepidopterología ·Giovanni Luca Ceresoli, Laura Mannarino, Lara Paracchini, Federica Grosso	0
4	Mechanism of efficacy of trabectedin against myxoid liposarcoma entails detachment of the FUS-DDIT3 transcription factor from its DNA binding sites 2024 ·Journal of Experimental & Clinical Cancer Research ·Ilaria Craparotta, Laura Mannarino, (unknown), (unknown), Sergio Marchini, Giulio Pavesi, Marta Russo, Salvatore Lorenzo Renne, (unknown), (unknown), Ezia Bello, Roberta Sanfilippo, Paolo G. Casali, Maurizio D’Incalci, Roberta Frapolli	0
5	In-Silico Identification of Novel Pharmacological Synergisms: The Trabectedin Case 2024 ·International Journal of Molecular Sciences ·Laura Mannarino, (unknown), Maurizio D’Incalci, Sergio Marchini, Marco Masseroli	1
6	A pan-cancer landscape of pathogenic somatic copy number variations 2023 ·Journal of Biomedical Informatics ·(unknown), Luca Beltrame, Laura Mannarino, Enrica Calura, Sergio Marchini, Chiara Romualdi	2
7	Important functional role of the protein osteopontin in the progression of malignant pleural mesothelioma 2023 ·Frontiers in Immunology ·Elisabeth Digifico, Marco Erreni, Laura Mannarino, Sergio Marchini, Aldo Ummarino, Clément Anfray, (unknown), Camilla Recordati, Daniela Pistillo, Massimo Roncalli, Paola Bossi, Paolo Andrea Zucali, Maurizio D’Incalci, Cristina Belgiovine, Paola Allavena	3
8	Cholesterol 24-hydroxylase is a novel pharmacological target for anti-ictogenic and disease modification effects in epilepsy 2022 ·Neurobiology of Disease ·Alessia Salamone, Gaetano Terrone, (unknown), Silvia Balosso, Teresa Ravizza, Luca Beltrame, Ilaria Craparotta, Laura Mannarino, (unknown), Massimo Rizzi, Alberto Pauletti, Sergio Marchini, Luca Porcu, Till S. Zimmer, Eleonora Aronica, Matthew J. During, Brett S. Abrahams, Shinichi Kondo, Toshiya Nishi, Annamaria Vezzani	14
9	Tumor treating fields affect mesothelioma cell proliferation by exerting histotype-dependent cell cycle checkpoint activations and transcriptional modulations 2022 ·Cell Death and Disease ·Laura Mannarino, (unknown), Nicolò Panini, Lara Paracchini, Sergio Marchini, Luca Beltrame, (unknown), Federica Grosso, Roberta Libener, Irene De Simone, Giovanni Luca Ceresoli, Paolo Andrea Zucali, Monica Lupi, Maurizio D’Incalci	4
10	Mechanisms of responsiveness to and resistance against trabectedin in murine models of human myxoid liposarcoma 2021 ·Genomics ·Laura Mannarino, Ilaria Craparotta, (unknown), Roberta Frapolli, (unknown), Ezia Bello, Nicolò Panini, Maurizio Callari, Roberta Sanfilippo, Paolo G. Casali, Marta Barisella, Chiara Fabbroni, Sergio Marchini, Maurizio D’Incalci	6
11	Tumor Immune Microenvironment and Genetic Alterations in Mesothelioma 2021 ·Frontiers in Oncology ·Stefanie Hiltbrunner, Laura Mannarino, Michaela B. Kirschner, Isabelle Opitz, (unknown), (unknown), Michela Lia, Paolo Nozza, Antonio Maconi, Sergio Marchini, Maurizio D’Incalci, Alessandra Curioni‐Fontecedro, Federica Grosso	32
12	The soluble glycoprotein NMB (GPNMB) produced by macrophages induces cancer stemness and metastasis via CD44 and IL-33 2020 ·Cellular and Molecular Immunology ·Manuela Liguori, Elisabeth Digifico, (unknown), (unknown), Federico Colombo, Elena Monica Borroni, Francesca Farina, Samantha Milanesi, (unknown), Laura Mannarino, Ilaria Craparotta, Sergio Marchini, Eugenio Erba, Nicolò Panini, Matteo Tamborini, Valeria Rimoldi, Paola Allavena, Cristina Belgiovine	89
13	Is DNA repair a potential target for effective therapies against malignant mesothelioma? 2020 ·Cancer Treatment Reviews ·Ilaria Fuso Nerini, Elisa Roca, Laura Mannarino, Federica Grosso, Roberta Frapolli, Maurizio D’Incalci	13
14	Combination of PPARγ Agonist Pioglitazone and Trabectedin Induce Adipocyte Differentiation to Overcome Trabectedin Resistance in Myxoid Liposarcomas 2019 ·Clinical Cancer Research ·Roberta Frapolli, Ezia Bello, (unknown), Ilaria Craparotta, Laura Mannarino, (unknown), Sergio Marchini, Laura Carrassa, Paolo Ubezio, Luca Porcu, Silvia Brich, Roberta Sanfilippo, Paolo G. Casali, Alessandro Gronchi, Silvana Pilotti, Maurizio D’Incalci	20
15	Establishment and characterisation of a new patient-derived model of myxoid liposarcoma with acquired resistance to trabectedin 2019 ·British Journal of Cancer ·Ezia Bello, Silvia Brich, Ilaria Craparotta, Laura Mannarino, (unknown), Raffaella Gatta, Sergio Marchini, Laura Carrassa, Cristina Matteo, Roberta Sanfilippo, Alessandro Gronchi, Paolo G. Casali, Silvana Pilotti, Maurizio D’Incalci, Roberta Frapolli	12
16	Targeted gene sequencing of Lynch syndrome–related and sporadic endometrial carcinomas 2018 ·Human Pathology ·(unknown), Ilaria Craparotta, Nora Sahnane, Anna Maria Chiaravalli, Laura Mannarino, Roberta Cerutti, Cristina Riva, Sergio Marchini, Daniela Furlan	7
17	Lurbinectedin reduces tumour-associated macrophages and the inflammatory tumour microenvironment in preclinical models 2017 ·British Journal of Cancer ·Cristina Belgiovine, Ezia Bello, Manuela Liguori, Ilaria Craparotta, Laura Mannarino, Lara Paracchini, Luca Beltrame, Sergio Marchini, Carlos M. Galmarini, Alberto Mantovani, Roberta Frapolli, Paola Allavena, Maurizio D’Incalci	119
18	A systems biology approach to investigate the mechanism of action of trabectedin in a model of myelomonocytic leukemia 2016 ·The Pharmacogenomics Journal ·Laura Mannarino, Lara Paracchini, Ilaria Craparotta, Michela Romano, Sergio Marchini, Raffaella Gatta, Eugenio Erba, Luca Clivio, Chiara Romualdi, Maurizio D’Incalci, Luca Beltrame, Linda Pattini	8
19	Identification of high-grade serous ovarian cancer miRNA species associated with survival and drug response in patients receiving neoadjuvant chemotherapy: a retrospective longitudinal analysis using matched tumor biopsies 2016 ·Annals of Oncology ·Marco Petrillo, Gian Franco Zannoni, Luca Beltrame, Elisa Martina Martinelli, Analisa DiFeo, Lara Paracchini, Ilaria Craparotta, Laura Mannarino, Giuseppe Vizzielli, Giovanni Scambia, Maurizio D’Incalci, Chiara Romualdi, Sergio Marchini	51
20	Regional and temporal heterogeneity of epithelial ovarian cancer tumor biopsies: implications for therapeutic strategies 2016 ·Oncotarget ·Lara Paracchini, Laura Mannarino, Ilaria Craparotta, Chiara Romualdi, Robert Fruscio, Tommaso Grassi, Vittoria Fotia, (unknown), Patrizia Perego, Enrica Calura, Luca Clivio, Maurizio D’Incalci, Luca Beltrame, Sergio Marchini	20

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact